SEC FORM 4
$2,911,849.36
BeOne Medicines Ltd. (ONC)
Sale of 8,081 shares at $360.3328 per share.
Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →